Institute of Medicine (U.S.). Board on Health Sciences Policy
Institute of Medicine (Spojené státy americké). Board on Health Sciences Policy
Institute of Medicine (Washington, DC) Board on Health Sciences Policy
Institute of Medicine (États-Unis). Board on Health Sciences Policy
VIAF ID: 144033976 ( Corporate )
Permalink: http://viaf.org/viaf/144033976
Preferred Forms
-
-
- 110 2 _ ‡a Institute of Medicine (U.S.) ‡b Board on Health Sciences Policy
- 110 2 _ ‡a Institute of Medicine (U.S.). Board on Health Sciences Policy
- 110 2 _ ‡a Institute of Medicine (U.S.). ‡b Board on Health Sciences Policy
-
- 110 2 _ ‡a Institute of Medicine (U.S.). ‡b Board on Health Sciences Policy
-
- 110 2 _ ‡a Institute of Medicine ‡g Washington, DC ‡b Board on Health Sciences Policy
4xx's: Alternate Name Forms (16)
5xx's: Related Names (7)
- 510 2 _ ‡a Health Sciences Policy Program (États-Unis)
- 510 2 _ ‡a Health Sciences Policy Program (U.S.)
- 510 2 _ ‡a Institute of Medicine Washington, DC
- 510 2 _ ‡a Institute of Medicine ‡g Washington, DC ‡e Ueberordnung
- 510 2 _ ‡a National Academies of Sciences, Engineering, Medicine ‡b Board on Health Sciences Policy ‡e Nachfolger
- 510 2 _ ‡a National Academies of Sciences, Engineering, and Medicine (U.S.). ‡b Board on Health Sciences Policy
- 551 _ _ ‡a Washington, DC
Works
Title | Sources |
---|---|
The 2009 H1N1 influenza vaccination campaign : summary of a workshop series | |
Adverse drug event reporting : the roles of consumers and health-care professionals : workshop summary | |
Alzheimer's diagnostic guideline validation : exploration of next steps : workshop summary | |
Applying an implementation science approach to genomic medicine, 2016: | |
Assessing the medical risks of human oocyte donation for stem cell research : workshop report | |
Autism and the environment : challenges and opportunities for research, workshop proceedings | |
BioWatch and public health surveillance : evaluating systems for the early detection of biological threats | |
Cancer and the environment : gene-environment interaction | |
Diffusion and use of genomic innovations in health and medicine : workshop summary | |
Ensuring safe foods and medical products through stronger regulatory systems abroad, 2012: | |
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary | |
Ethical considerations for research involving prisoners | |
Genomic epidemiology data infrastructure needs for SARS-CoV-2 : modernizing pandemic response strategies | |
Guidelines for human embryonic stem cell research | |
The Impacts of the affordable care act on preparedness resources and programs : workshop summary | |
Information sharing and collaboration : applications to integrated biosurveillance : workshop summary | |
Integrating large-scale genomic information into clinical practice : workshop summary | |
Measuring specific mental illness diagnoses with functional impairment : workshop summary | |
Military medical ethics : issues regarding dual loyalties : workshop summary | |
New frontiers in contraceptive research, c2003: | |
Perspectives on biomarker and surrogate endpoint evaluation : discussion forum summary | |
Policy and research needs to maximize independence and support community living : workshop summary | |
Post-incident recovery considerations of the health care service delivery infrastructure : workshop summary | |
Potential risks and benefits of gain-of-function research : summary of a workshop | |
Preparedness, response, and recovery considerations for children and families : workshop summary | |
Preparing for an influenza pandemic : personal protective equipment for healthcare workers | |
Prepositioning antibiotics for anthrax | |
Psychosocial interventions for mental and substance use disorders : a framework for establishing evidence-based standards | |
Public confidence and involvement in clinical research symposium summary, Clinical Research Roundtable, September 2000 | |
Rebuilding the unity of health and the environment : the greater Houston metropolitan area : workshop summary | |
Research and development of medical products | |
Reusability of facemasks during an influenza pandemic : facing the flu | |
Review of NASA's evidence reports on human health risks : 2015 letter report | |
Sharing clinical research data : workshop summary | |
Sharing clinical trial data : maximizing benefits, minimizing risk | |
Stabilizing the funding of NIH and ADAMHA ... 1985: | |
Stem cell therapies : opportunities for ensuring the quality and safety of clinical offerings : summary of a joint workshop | |
Strengthening the disaster resilience of the academic biomedical research community : protecting the nation's investment | |
Technologies to enable autonomous detection for BioWatch : ensuring timely and accurate information for public health officials : workshop summary | |
Testosterone and aging, c2004: | |
Total worker health | |
The use and effectiveness of powered air purifying respirators in health care : workshop summary |